Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Elizabeth, Chong"'
Autor:
Do-Youn Oh, Maria Alsina Maqueda, David I. Quinn, Peter J. O’Dwyer, Ian Chau, Sun Young Kim, Ignacio Duran, Daniel Castellano, Jordan Berlin, Begona Mellado, Stephen K. Williamson, Keun-Wook Lee, Francisca Marti, Paul Mathew, Muhammad Wasif Saif, Ding Wang, Elizabeth Chong, Jacqueline Hilger-Rolfe, James P. Dean, Hendrik-Tobias Arkenau
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background Ibrutinib, a first-in-class inhibitor of Bruton’s tyrosine kinase, is approved for the treatment of various B-cell malignancies and chronic graft-versus-host disease. Based on encouraging preclinical data, safety and efficacy of
Externí odkaz:
https://doaj.org/article/1fe44534f0e94c6a89809b887b29866b
Autor:
Nataliya Mar, Yousef Zakharia, Alejandro Falcon, Rafael Morales-Barrera, Begona Mellado, Ignacio Duran, Do-Youn Oh, Stephen K. Williamson, Pablo Gajate, Hendrik-Tobias Arkenau, Robert J. Jones, Min Yuen Teo, Tolga Turan, Robert T. McLaughlin, Hillary M. Peltier, Elizabeth Chong, Harisha Atluri, James P. Dean, Daniel Castellano
Publikováno v:
Cancers; Volume 15; Issue 11; Pages: 2978
Cancers, vol 15, iss 11
Cancers, vol 15, iss 11
Ibrutinib is a first-in-class Bruton’s tyrosine kinase inhibitor approved for the treatment of various B-cell malignancies and chronic graft-versus-host disease. We evaluated the safety and efficacy of ibrutinib, alone or combined with standard-of-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42cd390c1d0a005b308f5673e4a8ae57
Autor:
Vivian Vicet Isaac, Alina Velázquez Amador, Elizabeth Chong Hernández, Zaily Arévalo Gornache, Dianelis Gómez Rodríguez
Publikováno v:
Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta, Vol 41, Iss 11 (2016)
In diagnoses made to students of medical sciences, in the degree of health technology, difficulties were detected in the domain of written communication. The diagnosis was made to 40 students of the first year of the specialties of Dental Care and Ve
Externí odkaz:
https://doaj.org/article/41632618967f42718922a7da235b97d2
Publikováno v:
International Journal of Ophthalmology, Vol 6, Iss 3, Pp 381-384 (2013)
AIM: To identify the prevalence of retinopathy of prematurity (ROP) among preterm neonates admitted to Department of Neonatology, RIPAS hospital, Brunei Darussalam.METHODS: We studied 67 preterm infants fulfilling the eligibility criteria for ROP scr
Externí odkaz:
https://doaj.org/article/27b87c64d09241efae6837f2effa3827
Autor:
RIZAH MAZZUIN RAZALI, ELIZABETH CHONG GAR MIT, AARON HIEW WI HAN, ANDY QUAH JING YAO, ROSMAHANI MOHD ALI, UNGKU AHMAD AMEEN BIN UNGKU MOHD ZAM, NOR HAKIMA MAKHTAR, Tan, In Jiann, NOOR HARZANA HARRUN, NAGAMMAI THIAGARAJAN, TAY CHAI LI, NIK SUHAILA ZAKARIA, WONG PING FOO, NAJWA AZIZ, FARIDAH KUSNIN, NORAZILAH JAMIL, ANUSSA A/P KRISHNAN, LEE SOO CHENG, RUBAAN RAJ SILVERDURAI, HUMADEVI SIVASAMY, NORALIZA NORDIN MERICAN, SHELEASWANI INCHE ZAINAL ABIDIN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bfe2bd329f41b5dc5134219b3e06db9
Publikováno v:
Age and Ageing. 48:iv18-iv27
Introduction Hospital Kuala Lumpur is the largest tertiary hospital under the MoH. Inpatient falls is a setback in every health institution with ramifications to the patient’s well-being and the health organization image. Methodology This is a retr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5c9aad80cb10e2675e138a53b2fa070
https://doi.org/10.1093/ageing/afz164.96
https://doi.org/10.1093/ageing/afz164.96
Autor:
Siti Nur Fatihah Shaifol Akmar, Suzana Shahar, Nora Nurlinda Zakaria, Adeline Lo Li Ching, Norzainora Hamsah, Nur Shahirah Zulkifli, Muhammad Rabbani Abdul Malek, Elizabeth Chong Gar Mit
Publikováno v:
Jurnal Sains Kesihatan Malaysia. 17:115-124
Compliance rate towards consumption of oral nutritional supplement (ONS) is low among geriatric patients. Thus, this study aimed to examine factors affecting low compliance of ONS intake among a sample of geriatric patients. A cross-sectional survey
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba43fafc29fb8601051f2f3b5f2b2a69
https://doi.org/10.17576/jskm-2019-1701-15
https://doi.org/10.17576/jskm-2019-1701-15
Autor:
Shiquan Wu, Shuo Ma, Shachar Peles, Israel Arango-Hisijara, Bernhard Hauns, Kevin A. Kwei, Franck Morschhauser, Elizabeth Chong, Morton Coleman, Graham P. Collins, Sven de Vos, Jacqueline C. Barrientos, Stephen D. Smith, Robert T. Chen, Peter Martin, Catherine Thieblemont, Christopher R. Flowers, Leo W.-K. Cheung, Ariela Noy
Publikováno v:
Blood advances. 4(22)
Advanced marginal zone lymphoma (MZL) is an incurable B-cell malignancy dependent on B-cell receptor signaling. The phase 2 PCYC-1121 study demonstrated the safety and efficacy of single-agent ibrutinib 560 mg/d in 63 patients with relapsed/refractor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23c1b58f1fb2d03d2add57f55c2e2c56
https://pubmed.ncbi.nlm.nih.gov/35842643
https://pubmed.ncbi.nlm.nih.gov/35842643
Autor:
Elizabeth Chong
Publikováno v:
RECAI Revista de Estudios en Contaduría, Administración e Informática, Vol 6, Iss 17, Pp 1-20 (2017)
Elizabeth Chong
Elizabeth Chong
Este artículo muestra los beneficios que las mujeres han obtenido al capacitarse en el ámbito técnico y personal para aplicarlo en sus negocios. Por la naturaleza de los datos, el estudio es de tipo cualitativo y descriptivo. Se consideraron nueve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0fd03fe4d05044d0808628de7c4f01df
https://recai.uaemex.mx/article/view/8997
https://recai.uaemex.mx/article/view/8997
Autor:
Dan Jones, Kevin A. Kwei, Adrian Wiestner, Danelle F. James, Leo W. K. Cheung, Jennifer A. Woyach, Inhye E. Ahn, James P. Dean, John C. Byrd, Susan O'Brien, Paolo Ghia, Carol Moreno, Elizabeth Chong
Publikováno v:
Blood. 136:32-33
Background : Ibrutinib (Ibr) is the only once-daily Bruton's tyrosine kinase (BTK) inhibitor with significant survival benefit vs chemo- and/or immunotherapy in multiple phase 3 studies of patients (pts) with CLL. Ibr in first-line (1L) CLL is associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a751643a59c42a766fadd26be216915f
https://doi.org/10.1182/blood-2020-134386
https://doi.org/10.1182/blood-2020-134386